U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809659) titled 'CanRisk-Based Ovarian Cancer Risk Assessment Versus Standard Practice (DISARM CSA)' on July 22.
Brief Summary: The purpose of this study is to improve how the risk of developing ovarian cancer is assessed in people who may be at increased risk of ovarian cancer due to their family history or genetic background.
In current clinical practice, ovarian cancer risk assessment usually relies on information about cancer in the family and, in some cases, genetic testing for certain genes known to be associated with ovarian cancer. While this approach is commonly used, the inclusion of additional factors may support more personalised ovari...